Navigation Links
LegalView Updates its Baxter Heparin Information Portal with Conflicting News Reports on the Possible Dangers
Date:12/25/2008

LegalView informed individuals of recent conflicting news reports on the ongoing Baxter Heparin blood thinner controversy. The FDA has claimed that Baxter's Heparin was not the cause of death among several patients, but the agency has also alleged that that the tainted blood thinner likely did cause death among patients.

Denver, CO (PRWEB) December 25, 2008 -- LegalView.com, the number one legal resource available on the Internet, recently used its Baxter heparin information portal to report on additional controversy plaguing patients of the blood thinner. According to news reports, Rep. Joe Barton of Texas has claimed that the U.S. Food and Drug Administration (FDA) has given conflicting reports on the blood thinner, which is often given to prevent blood clots during surgical procedures including heart failure and kidney transplants, saying the drug was both responsible and not responsible for deaths of Americans. Rep. Barton has called for a Government Accountability Office (GAO) investigation into the FDA's remarks on the blood thinner.

Baxter Heparin has been at the center of a controversy this year as it was discovered that a tainted batch of heparin was given to hundreds of Americans causing allergic reactions and deaths among dozens of patients, according to news reports. The tainted heparin was eventually found to have been contaminated with a chemical known as over-sulfated chondroitin sulfate in a Chinese manufacturing plant. Not only was a heparin recall implemented, but an investigation spanning international borders was developed. A New England Journal of Medicine article from Dec. 3 claimed that the blood thinner could not have caused the deaths of several individuals, however this contradicted the FDA's previous remarks in May, which claimed that the drug was responsible for the deaths of patients, according to Dow Jones news reports.

Patients who have previously been administered the blood thinner are advised to locate an experienced Baxter heparin attorney who can offer a free legal consultation as to the development of a potential heparin class action lawsuit. Developing such litigation may offer monetary assistance to victims of the Heparin side effects and may help in paying for medical bills associated with the drug.

LegalView also offers several additional pharmaceutical practice areas on an array of topics ranging from Avandia and Byetta to the recent Chantix controversy. Both Avandia and Byetta are type 2 diabetes prescription medications, however, each drug has been in the news for different, yet severe side effects.

Avandia, from GlaxoSmithKline, uses an individual's natural insulin and regulates it in order to keep glucose on a normal and healthy level. However, the drug has been linked to severe risks including bone fractures among women, early onset osteoporosis and heart failure/damage among patients. Individuals who have suffered from the Avandia side effects are advised to contact a pharmaceutical attorney in addition to their regular medical physician.

Byetta, similar to Avandia, is a type 2 diabetes prescription medication that was released in mid-2005. In 2007, the FDA began receiving reports from Byetta patients who were suffering from pancreatitis as an unintended side effect associated with consumption of the drug. Patients who suffered from these dangers should seek legal counsel from an experienced Byetta law firm to learn more about the dangers associated with consumption of the medication.

An additional pharmaceutical prescription drug, which has sparked FDA investigations is that of Chantix, a smoking cessation drug that has been used by nearly 3 million Americans since its release in May 2006. At the end of 2007, however, hundreds of reports regarding dangerous side effects caused by the drug flooded the FDA offices. Chantix patients were allegedly developing conditions such as depression, mood disorders as well as suicidal tendencies and actions. There have allegedly been approximately 40 suicides linked to the use of Chantix, which is why it is imperative that smokers using the drug as an aid to quit smoking talk with their physician about alternative cessation methods. Additionally, it may be necessary for those individuals affected by the Chantix dangers to locate a pharmaceutical attorney for the potential development of a Chantix lawsuit.

About LegalView

LegalView.com is a public service brought to you by Legal WebTV Network, LLC, a Limited Liability Corporation created by a group of the nation's most highly respected law firms: Anapol Schwartz; Brent Coon and Associates; Burg Simpson; Cohen, Placitella and Roth; James F. Humphreys and Associates; Lopez McHugh; and Thornton and Naumes. For more information on the accomplishments and track records of LegalView.com's superior sponsoring law firms and to get in touch with LegalView attorneys, visit LegalView at www.LegalView.com.

###

Read the full story at http://www.prweb.com/releases/2008/12/prweb1792594.htm


'/>"/>
Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved

Related medicine news :

1. LegalView Reveals Details of the FDA Mandated Black Box Warning For Fluoroquinolone Antibiotics Such as Cipro and Levaquin
2. LegalView Unveils Details of a Breakthrough Mesothelioma Cancer Early Detection Test for Mesothelioma Patients
3. LegalView Brain Injury Site Reports Department of Veteran Affairs Request for Research on TBI and Soldiers
4. LegalView Highlights Top Brain Injury Rehabilitation Hospitals in the United States - 5.3 Million Americans Suffer from TBI
5. LegalView Reports Details of War Veteran Brain Injuries Overlooked By Officials for Years
6. LegalView Warns Proton Pump Inhibitor Patients of Potential Bone Fracture Risk Associated with Drug
7. LegalView Re-launching Truck Accident Injury Information Portal with Updated News and Information on the Costly and Dangerous Accidents
8. LegalView Reports Cancer Risk for St. Louis Residents After Unapproved Asbestos Removal During Demolition
9. LegalView Informs Patients of Possible Cimzia Cancer Link, Drug Commonly Used to Treat Arthritis
10. LegalView Reintroduces its Medical Malpractice Information Portal with Updated Links to Finding Immediate Legal Assistance
11. LegalView Re-Launches its Avandia Information Portal with News of the Type 2 Diabetes Drug's Risks and Dangers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... ... , ... Mediaplanet is proud to announce the launch of ... treatments, therapeutic technologies, and revolutionized nutrition that are helping patients and physicians manage ... in the last 3 decades,” says Dr. Valentine Fuster, a world-renowned cardiologist. “This ...
(Date:12/2/2016)... ... , ... Rijuven Corp launches rejiva ( http://www.rejiva.com ), a unique wearable technology ... health technology on the market can deliver all that rejiva can. , “Rejiva promotes ... their health than the usual heart rate and steps taken”, adds Evens Augustin, CEO ...
(Date:12/2/2016)... ... December 02, 2016 , ... Today ... intelligent, connected applications, was named the best Sales Team of 2016 as part ... was made today by the Software & Information Industry Association (SIIA), the principal ...
(Date:11/30/2016)... ... , ... "I hate when the mixture of saliva and toothpaste runs down ... from Bridgewater, N.J. "I thought that there had to be a way to prevent ... patent-pending DEFLECTOR to prevent saliva and toothpaste from running down the brush handle onto ...
(Date:11/30/2016)... U.K. (PRWEB) , ... November 30, 2016 , ... ... address the tech functions and stylish design wanted by today’s consumers at an ... Cronovo Co-Founder Darin Philip says the new watch is “a game changer” when ...
Breaking Medicine News(10 mins):
(Date:12/2/2016)... WOONSOCKET, R.I. , Dec. 2, 2016 ... hold its annual Analyst Day in New York City on Thursday, December ... the CVS Health leadership team will provide an in-depth ... and enhance shareholder value. The company will also discuss ... audio and video webcast of the event will be ...
(Date:12/2/2016)... 2, 2016 Orthopedic Implants (Including Spinal ... Expected to Gain a Significant Market Share Owing to a ... ... According to a new report by ... Sterile Packaging: Clamshell Product Type Segment Projected to Witness a ...
(Date:12/2/2016)... N.J. , Dec. 2, 2016   CytoSorbents ... immunotherapy leader commercializing its European Union approved CytoSorb ... and cardiac surgery patients worldwide, announced that Dr. ... the 9th Annual LD Micro Main Event ... , 2016 at the Luxe Sunset Boulevard Hotel in ...
Breaking Medicine Technology: